GRECCAR2 trial: details worthy of more attention - Authors' reply
Lancet
.
2018 Jan 13;391(10116):122-123.
doi: 10.1016/S0140-6736(18)30016-3.
Authors
Eric Rullier
1
,
Véronique Vendrely
2
,
Quentin Denost
3
,
Julien Asselineau
4
,
Adélaïde Doussau
4
Affiliations
1
Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France. Electronic address:
[email protected]
.
2
Radiotherapy, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
3
Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
4
Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique du CHU de Bordeaux, Université Bordeaux, Bordeaux, France.
PMID:
29353619
DOI:
10.1016/S0140-6736(18)30016-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Rectal Neoplasms / therapy*